Que Dallara
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Lattice Semiconductor Shares Fall Amid Broader Chip Sector Decline. Lattice Semiconductor stock declined as part of a wider drop in semiconductor shares driven by concerns over AI investment levels. The company is trading near its 52-week low, a level it has tested multiple times recently. While Lattice is involved in open AI infrastructure initiatives, the immediate market reaction reflects broader sector sentiment rather than company-specific news.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Honeywell Q3 Earnings Expected to Decline. Honeywell’s upcoming third‑quarter earnings are projected to fall short of previous results. Analysts point out that the company’s long‑term outlook still looks appealing. A recent comparison article suggests Honeywell may be a stronger choice than Corning for 2026.
Transaction History
| MMED | ▼ Sell | Tax Withholding | 31,350 | $569K | 7/31/2026 | View on chart |
| MMED | ▲ Buy | Grant | 297,618 | $0 | 7/1/2026 | View on chart |
| LSCC | ▲ Buy | Grant | 1,752 | $0 | 5/4/2026 | View on chart |
| MMED | ▼ Sell | Tax Withholding | 4,809 | $78K | 3/25/2026 | View on chart |
| MMED | ▲ Buy | Grant | 80,842 | — | 3/11/2026 | View on chart |
| MMED | ▲ Buy | Grant | 51,044 | — | 3/11/2026 | View on chart |
| MMED | ▲ Buy | Grant | 22,892 | — | 3/11/2026 | View on chart |
| MMED | ▲ Buy | Grant | 57,239 | — | 3/11/2026 | View on chart |
| MMED | ▲ Buy | Grant | 281,937 | — | 3/11/2026 | View on chart |
| MMED | ▲ Buy | Grant | 127,609 | — | 3/11/2026 | View on chart |
| LSCC | ▲ Buy | Option Exercise | 2,671 | $0 | 5/6/2025 | View on chart |
| LSCC | ▲ Buy | Grant | 4,193 | $0 | 5/5/2025 | View on chart |
| LSCC | ▲ Buy | Option Exercise | 1,621 | $0 | 5/8/2024 | View on chart |
| HON | ▲ Buy | Option Exercise | 1,186 | — | 2/27/2022 | View on chart |
| HON | ▼ Sell | Tax Withholding | 536 | $100K | 2/27/2022 | View on chart |
| HON | ▲ Buy | Grant | 4,383 | $0 | 2/26/2022 | View on chart |
| HON | ▼ Sell | Tax Withholding | 1,977 | $370K | 2/26/2022 | View on chart |
| HON | ▲ Buy | Option Exercise | 994 | — | 2/14/2022 | View on chart |
| HON | ▼ Sell | Tax Withholding | 449 | $84K | 2/14/2022 | View on chart |
| HON | ▲ Buy | Option Exercise | 924 | — | 1/13/2022 | View on chart |
| HON | ▼ Sell | Tax Withholding | 444 | $98K | 1/13/2022 | View on chart |
| HON | ▼ Sell | Tax Withholding | 1,166 | $239K | 12/26/2021 | View on chart |
| HON | ▲ Buy | Option Exercise | 2,584 | — | 12/26/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
MiniMed Set for Medtronic Split-Off, Analysts Set New Targets
Medtronic has finalized the exchange ratio for the MiniMed split-off, a key corporate event for the stock. Meanwhile, Mizuho raised its price target to $28, while Barclays initiated coverage with a lower target of $22. Recent studies also highlighted that responding to MiniMed's diabetes alerts is linked to better glucose outcomes.
MiniMed Set for Medtronic Split-Off, Analysts Set New Targets. Medtronic has finalized the exchange ratio for the MiniMed split-off, a key corporate event for the stock. Meanwhile, Mizuho raised its price target to $28, while Barclays initiated coverage with a lower target of $22. Recent studies also highlighted that responding to MiniMed's diabetes alerts is linked to better glucose outcomes.